Search Results 301-310 of 13645 for monoclonal antibody

  1. Intestinal Cancer Clinical Trials - Mayo Clinic Research

    Ramucirumab is a monoclonal antibody that attaches to and inhibits a molecule called VEGFR-2. This may restrain new blood vessel formation therefore ...

  2. Pertuzumab-dpzb (intravenous route) - Side effects & uses - Mayo Clinic

    HER2 protein is produced by some tumors. Pertuzumab-dpzb is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed ...

  3. Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic

    ... monoclonal antibody therapy prior to anti-EGFR monoclonal antibody therapy. For those with left-sided tumors, the data are less clear. However, we at least ...

  4. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibodies: Update on this COVID-19 experimental therapy featured image. COVID-19. Monoclonal antibodies: Update on this COVID-19 experimental ...

  5. Rituximab-abbs (intravenous route) - Side effects & uses - Mayo Clinic

    Rituximab-abbs is a monoclonal antibody. Rituximab-abbs injection is used together with other cancer medicines (eg, fludarabine and cyclophosphamide) to ...

  6. Publications - Melissa R. Snyder, Ph.D. - Mayo Clinic

    Lack of observed interference by therapeutic monoclonal antibodies ... Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and ...

  7. Mayo Clinic Q and A: Medications in use and being tested for treatment of COVID-19

    Monoclonal antibodies are proteins created in a lab that can help the immune system fight off viruses. Several monoclonal antibody medications are available.

  8. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  9. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  10. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find ...